SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Emily Dickinson — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEmily Dickinson
Date of birth1830-12-10
IdentifiersMRN HR-NI023-SYN-TD; SSN (made up) 000-23-6081
Document date1885-10-19
AuthorLucinda Hartwell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic preventive visit; no new complaints. [S]

History of Present Illness

Ms. Dickinson is a 54-year-old woman with stage G3a A2 chronic kidney disease and hypertension who comes to the clinic for her periodic preventive visit, three weeks after her six-month kidney review by video. She chose a quiet first appointment of the morning and asked that her vaccines, cervical screening, and mammogram be done on this one trip; her second hepatitis B dose was held for today for the same reason. She completed the health risk assessment at home and sent it in beforehand. She has had no headaches for several months. She takes losartan 100 mg, dapagliflozin 10 mg, amlodipine 5 mg, atorvastatin 20 mg, and vitamin D3 daily, and she has taken no NSAIDs. She has had no illness since the gastroenteritis in April. Her home blood pressure averages 118/72. She writes most mornings and works in her garden most afternoons. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 54
Safety eventsNo falls, emergency visits, or hospital stays this year
MedicinesTaken daily from a weekly organizer; sick-day card in her medicine cabinet; no NSAIDs or supplements other than vitamin D3
Active conditionsChronic kidney disease G3a A2 with albuminuria falling on treatment; hypertension at target; vitamin D deficiency treated
Functional statusIndependent in all activities of daily living; writes full mornings and gardens most afternoons

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, better than at the start of the year
PsychosocialContent at home; writes to a few close friends; feels well supported by her household; does not feel lonely
TobaccoNever used tobacco
Alcohol and drugsNo alcohol (AUDIT-C 0); no other drug use
Physical activityGarden work and walking in her garden about 160 minutes a week
NutritionCooks at home with little added salt; plenty of vegetables and fruit from her garden
SleepAbout seven hours a night since the headaches stopped
Activities of daily livingIndependent
Instrumental activities of daily livingIndependent; another household member drives and runs errands
Home safetySmoke detectors working; no firearms in the home
Hearing and visionHears well; uses reading glasses; no eye examination for several years
SafetyWears a seat belt; does not drive

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; no fever or fatigue
EyesNegativeNo eye pain, redness, light sensitivity, or change in vision
Ears, nose, mouth, and throatNegativeNo hearing loss or dental pain
CardiovascularNegativeNo chest pain, palpitations, ankle swelling, or lightheadedness
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo nausea, change in bowel habit, or bleeding
GenitourinaryNegativeNo urinary symptoms or genital infections on dapagliflozin; postmenopausal for three years with no bleeding
MusculoskeletalNegativeNo joint pain or muscle aches on atorvastatin
IntegumentaryNegativeNo new or changing skin lesions
NeurologicalNegativeNo headaches for several months; no numbness or weakness
PsychiatricNegativeMood good; PHQ-2 0 and GAD-7 3
BreastNegativeNo lumps, pain, or nipple discharge

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen sodium 220 mg oral tablet, two tablets by mouth as needed for headache (over the counter)Two tablets as needed, up to twice a dayOral route1884-10-01 to 1885-01-12stoppedS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-01-12 to 1885-02-02completedS
Losartan 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-02-02activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-01-12activeS
Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-01-12activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a dayTwo tablets every 6 hours as needed; maximum 6 tablets a dayOral route1885-01-12activeS
Dapagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-02-02activeS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1885-03-02activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1885-10-19Body height163cmS
1885-10-19Body weight53.5kgS
1885-10-19Body mass index (BMI) [Ratio]20.1kg/m2S
1885-10-19Systolic blood pressure120mm[Hg]S
1885-10-19Diastolic blood pressure74mm[Hg]S
1885-10-19Heart rate70/minS
1885-10-19Respiratory rate14/minS
1885-10-19Body temperature36.6CelS
1885-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1885-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1885-10-19Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S
1885-10-19Total score [AUDIT-C]0{score}S

Physical Exam

Vital signs recorded on 1885-10-19; see the Vital Signs section. [S]

SystemFinding
ConstitutionalSlight, well woman; weight 53.5 kg, BMI 20.1
EyesPupils equal and reactive; undilated fundi show mild arteriolar narrowing without hemorrhages or exudates
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm at 70 per minute; no murmur; no edema
RespiratoryClear
BreastNo masses, skin changes, or axillary nodes
AbdomenSoft and non-tender; no masses or bruits
PelvicNormal external genitalia, vagina, and cervix; HPV sample collected
SkinNo suspicious lesions
PsychiatricCalm and engaged; euthymic

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic kidney disease stage G3a A2, attributed to hypertension; synthetic modern diagnosis linked to the Bright's disease entered on her death certificateactiveconfirmed N18.31S — Synthetic modern diagnosis. Bright's disease as her recorded cause of death is documented (D); what it meant in her case is a retrospective question (R), and no kidney test from her lifetime exists.
Hypertension with chronic kidney disease (hypertensive chronic kidney disease, stage 3a); synthetic modern diagnosis linked to the retrospective view that she had severe hypertensionactiveconfirmed I12.9S — Synthetic modern diagnosis; severe hypertension is a retrospective interpretation (R, possible), and no blood pressure from her lifetime exists.
Vitamin D deficiency with a mildly raised PTH in chronic kidney diseaseactiveconfirmed E55.9S — Synthetic laboratory finding at the intake visit.
Viral gastroenteritis with volume depletion and a prerenal rise in creatinine while taking losartan and dapagliflozin; resolvedresolvedconfirmed A08.4S — Synthetic illness at an unscheduled home visit, chosen to teach sick-day rules in chronic kidney disease; it does not echo any documented illness.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressureCompleted today120/74 mmHg; treated hypertension at target
Cholesterol and statinUp to dateLipid panel in January; on atorvastatin for chronic kidney disease, without routine repeat testing
Diabetes screeningUp to dateHbA1c 5.5 percent in January; repeat in three years
Breast cancer screeningOrderedNo mammogram for four years because of the travel involved. Biennial screening from 40 to 74 discussed; a screening mammogram is booked at the imaging suite downstairs straight after this visit, so it needs no extra trip
Cervical cancer screeningCompleted todayPrimary HPV test collected today, about six years after her last screen; result by letter. If negative, repeat in five years
Colorectal cancer screeningOrderedNo prior screening. Options discussed; she chose a yearly fecal immunochemical test she can do at home, and a kit was given today. A positive test needs colonoscopy
Osteoporosis screeningNot indicatedPostmenopausal and under 65; FRAX ten-year major osteoporotic fracture risk 5.8 percent, below the threshold for bone density testing. Review yearly, given her low body weight and chronic kidney disease
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever used tobacco
Depression screeningCompleted todayPHQ-2 score 0; PHQ-9 3 in June
Anxiety screeningCompleted todayGAD-7 score 3
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 0
Hepatitis C and HIV screeningUp to dateBoth negative five years ago; no new risk
Hepatitis B vaccineCompleted todayDose 2 of HepB-CpG given today, completing the two-dose series begun in June
Influenza vaccine, this seasonCompleted todayGiven today
Recombinant zoster vaccineCompleted todayDose 1 given today; dose 2 in two to six months, which can be given at a home visit
Pneumococcal vaccineUp to datePCV20 in January; no further doses needed
COVID-19 vaccine, this seasonDueRecommended; she will have it at the zoster dose 2 home visit
Tetanus, diphtheria, and pertussis boosterUp to dateTdap seven years ago; next due in three years
Eye examinationReferredDilated eye examination for hypertension, which the CMID advises yearly; she had eye treatment for light sensitivity long ago and none recently. Booked with the optometrist in this building on the day of her next clinic trip
Dental examinationDueNo dental visit for two years; she will book one

Immunizations given today: Hepatitis B vaccine, CpG-adjuvanted (HepB-CpG), dose 2 of 2; Influenza vaccine, 1885-1886 season; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, and depression monographs (2026); Adult Immunization Schedule by Age (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026)

Follow-up: Mammogram straight after this visit. Return the stool test kit within two weeks. Zoster dose 2 and the COVID-19 vaccine at a home visit in two to six months. Yearly kidney tests and review in January. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent from her household and completed a health care proxy form; the agent is recorded in the chart and is not named here. She said that what matters most to her is staying in her own home, keeping her privacy, and being able to write. She wants full treatment for reversible illness, with care at home whenever it is safe. She would not want dialysis started without a frank discussion of what it would mean for her daily life, and she asked for information about conservative kidney care for the future. She chose not to record other specific treatment preferences today. The plan will be revisited yearly and at any change in kidney function. [S]